ADMA Q1 2017 Earnings — ADMA Biologics, Inc. Revenue & Financial Results | Market Cap Arena

ADMAADMA Biologics, Inc.

$4B

Q1 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M+23.8% YoY

Gross Profit

$1M38.5% margin

Operating Income

-$6M-225.8% margin

Net Income

-$7M-248.7% margin

EPS (Diluted)

$-0.51

QoQ Revenue Growth

-21.0%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$5M

Stock-Based Comp.

$235,877

Balance Sheet

Total Assets

$18M

Total Liabilities

$28M

Stockholders' Equity

-$11M

Cash & Equivalents

$9M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$2M	+23.8%
Gross Profit	$1M	$857,465	+18.1%
Operating Income	-$6M	-$4M	-42.8%
Net Income	-$7M	-$5M	-41.7%

Revenue Segments

Plasma Collection Center Member

$3M99%

Corporate Member

$35,7081%